Ipamorelin versus GHRP-2
GHRP-2 was developed as an improvement over GHRP-6, and it is in some ways. The hunger effect is reduced compared to GHRP-6, though still present. GHRP-2 is more potent for growth hormone release, producing la…
Comparison
Ipamorelin side effects: Topic comparisons
Approved comparison material connected to this topic.
8 total recordsSide-by-side reading
Comparison records
Source comparisons are presented without a generated winner.
Read comparison →
Ipamorelin side effects versus other growth hormone peptides
Context matters when evaluating side effects. Ipamorelin's profile looks even better when compared to alternatives. Understanding these comparisons helps you appreciate why ipamorelin is often the first choice…
Ipamorelin versus sermorelin
Sermorelin is a growth hormone releasing hormone analog rather than a ghrelin mimetic like ipamorelin. It works through a different receptor system to achieve similar ends. The side effect profile is comparabl…
Ipamorelin versus GHRP-6
GHRP-6 is an older growth hormone secretagogue with a very different side effect profile. The most notorious difference is hunger. GHRP-6 causes intense, sometimes overwhelming hunger that makes it difficult t…
Ipamorelin versus MK-677
MK-677, also known as ibutamoren, is often compared to ipamorelin though it is not technically a peptide. It is an oral growth hormone secretagogue, which makes it convenient, but this comes with different con…
Ipamorelin Side Effects: Clinical Comparison
Water retention (hands, feet, face) 15–25% 24–48 hours post-injection 4–6 hours per episode; resolves after 2 weeks GH-induced sodium reabsorption in renal distal tubules Normal response; self-limiting; reduce…
Ipamorelin Side Effects Long Term Research: Safety vs Efficacy Comparison
Serious Adverse Events (Grade ≥3) <3% (Mayo Clinic, UVA trials) 12–18% (peripheral edema, carpal tunnel, joint pain) 8–14% (cortisol-mediated insulin resistance) Ipamorelin demonstrates the lowest SAE rate acr…
Tesamorelin + Ipamorelin Blend Side Effects: Clinical vs Anecdotal Comparison
Injection site erythema/swelling 15–30% (Grade 1 only) Within 6–24 hours post-injection 24–72 hours in 85% of cases Mechanical tissue stretch + histamine release from rapid injection Technique-dependent. Slowe…